Blog Detail
The IN VIVO Blog
http://invivoblog.blogspot.com
News, insight and analysis on the business of the biopharmaceutical industry from the editors of Windhover Information and FDC Reports, publishers of IN VIVO and "The Pink Sheet".
- Added on: Jan 20th, 2009
- Country: United States
- Language: English
- Author: Adam Gordon
- Listed in: Mergers & Acquisitions Health
- Tags: acquisitions biotechnology pharmaceutical mergers alliances dealmaking
Recent Posts
Deals of the Week: Merry Chrismahanukwanzakah
It's that time of year. Time for making merry with wassail, carbohydrates, and Tiny Tim-isms. In the spirit of inclusion, it's tempting to spit "Bah, Humbug," but Joe Lieberman beat us to it.Perhaps three ghosts will haunt the Connecticut Senator in ...
Financings of the Fortnight Needs a Top-Up
Sometimes, we need a little extra. Know what we mean?A little extra sleep--just five more minutes... Maybe just one more beer, sure. OK just one more holiday cookie ... an extra day to finish the 'Financings of the Fortnight' post. But this past coup...
2009 M&A/Alliance DOTY Nominee: Sanofi-Aventis/Regeneron
It's time for the IN VIVO Blog's Second Annual Deal of the Year! competition. This year we're presenting awards in three categories--that's 300% more fake prizes than last year!--to highlight the most interesting and creative deal making solutions of...
For Adimab, Deals and Deal Milestone Payments Come in Twos
Adimab, the yeast-based antibody discovery play, will announce this morning that it added two new collaborations to the Merck and Roche deals it announced over the summer. And Tillman Gerngross, Adimab's co-founder and CEO, tells us the company plans...
2009 Big Pharma DOTY Nominee: Abbott/Solvay and the Foreign Cash Dilemma
It's time for the IN VIVO Blog's Second Annual Deal of the Year! competition. This year we're presenting awards in three categories--that's 300% more fake prizes than last year!--to highlight the most interesting and creative deal making solutions of...
PhRMA Wins Reimportation Battle; Can it Win the PR War
The brand name pharmaceutical industry staved off an effort to attach a reimportation provision to the Senate health care reform bill last night. If anyone doubted how much the trade association PhRMA accomplished by working with the White House on r...
